Alfred Altomari - Oct 13, 2021 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Chief Executive Officer, Director
Signature
/s/ Al Altomari
Stock symbol
AGRX
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
4
Date filed
10/14/2021, 08:00 AM
Previous filing
Jul 29, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Purchase +58.8K +11.42% 574K Oct 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Warrants (right to buy) Purchase +29.4K 29.4K Oct 13, 2021 Common Stock 29.4K $0.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased the reported securities at a combined public offering price of $0.85 per one share of common stock together with one-half of a warrant to purchase one share of common stock.